Loading...
Loading...
NeuroMetrix, Inc.
, a medical device company focused on the
treatment and management of chronic pain, today announced that it had entered
into an agreement with OsteoArthritis Centers of America, a subsidiary of
Rehabilitation Management Group (RMG) which is a national physician consulting
company, to incorporate the SENSUS^™ Pain Management System into its
affiliated medical clinics.
The SENSUS Pain Management System is a convenient and wearable non-invasive
electrical nerve stimulator that offers patients a fast-acting, non-narcotic
option for relief from chronic pain. The device is lightweight and can be worn
during the day while remaining active, or at night while sleeping. It is
specifically designed for people with diabetes that suffer from chronic pain.
The most common cause of such pain is painful diabetic neuropathy (PDN), which
affects up to 5 million people in the U.S. alone.
There are over 100 medical clinics throughout the US that operate as
affiliates of RMG and the Osteoarthritis Centers of America. Accredited
providers offer a variety of services to their patients including programs to
relieve chronic pain, such as that due to painful diabetic neuropathy. A
growing number of clinics offer RMG's proprietary Neuropathy Medical Program.
As part of this agreement, SENSUS will be incorporated into the program as an
option when medically indicated.
Loading...
Loading...
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in